Xspray Pharma AB Announces to Present Data At ASCO Highlighting Frequent Decideication of PPIs with TKIs in CML-Patients and Greater Than Expected Positive Effects on the Bioavailability of Crystalline Dasatinib

Xspray Pharma AB announced the online publication of its abstract titled Frequency of comedyication of Proton Pump Inhibitors with Crystalline Dasatinib in Chronic Myeloid Leukemia and Effects on...

Related Keywords

Sweden ,Uppsala ,Uppsala Lan ,United States ,Swedish ,American , ,University Hospital ,Uppsala University ,American Society Of Clinical Oncology ,Karolinska Institute ,Xspray Pharma ,Proton Pump Inhibitors ,Crystalline Dasatinib ,Chronic Myeloid Leukemia ,American Society ,Clinical Oncology ,Annual Meeting ,Tyrosine Kinase Inhibitors ,